Business Wire

Vneuron Risk and Compliance Voted Best Anti-Money Laundering Compliance Solution Provider in Waters Rankings Awards 2023

Share

Vneuron Risk & Compliance is honored to announce its selection as the "Best AML Compliance Solution Provider'' for 2023 by Waters Rankings Readers and its esteemed clientele. This prestigious recognition stems from the publisher's annual voting, solidifying Vneuron's industry standing.

The twenty-first edition of the Waters Rankings awards competition showcased 35 awards across five categories, including trading services, trading tools, data management, compliance risk management, and infrastructure/connectivity. Each award acknowledges the outstanding global excellence of the ultimate winner.

In the category of Best AML Compliance Solution Provider, Vneuron Risk & Compliance has emerged victorious among 17 nominated global providers, a remarkable feat considering the previous dominance of legacy vendors in this category. This accomplishment underscores Vneuron's dedication to bringing the most advanced technologies for efficiently combating money laundering and terrorism financing on a global scale.

Vneuron has garnered significant recognition in the market following its successful integration of comprehensive regulatory coverage with advanced technologies. This unique approach allows Vneuron to offer automated Know Your Customer (KYC) procedures and screening workflows, along with real-time transaction filtering and AI-powered monitoring. Furthermore, Vneuron provides case management and dynamic investigation capabilities, reinforcing its comprehensive suite of services.

Furthermore, Vneuron addresses the challenge of maintaining compliance while enhancing the customer experience. User-friendly digital portals and self-onboarding tools engage customers throughout the onboarding and review processes, facilitating efficient fulfillment of KYC obligations. Additionally, its process automation engine, integrated into the customer lifecycle platform and KYC component, ensures swift approvals and investigations.

To learn more about Vneuron’s solutions, visit www.vneuron.com

About the Company:

Vneuron, an innovative Anti-Money Laundering (AML) technology provider, designs and implements robust regulatory solutions for over 200 financial institutions across Europe, the Middle East, and Africa. With its headquarters in France, Vneuron is committed to offering customizable solutions tailored to the needs of modern banks as well as non-banking financial institutions, encompassing insurance, capital markets, lending, and FinTech sectors.

About Waters Rankings:

For over two decades, Waters Rankings has provided technology and data insights for the finance industry. With researchers in London, New York, and Hong Kong, the magazine ensures global exposure to financial markets. Through in-depth investigations, readers gain a comprehensive understanding of technology providers.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For media inquiries, please contact:
Ameni Naimi
press@vneuron.com

For Other inquiries
hello@vneuron.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

EIG’s MidOcean Energy Completes Acquisition of Interest in Canada from PETRONAS17.12.2025 10:58:00 EET | Press release

MidOcean Energy (“MidOcean”), a liquefied natural gas (LNG) company formed and managed by EIG, a leading institutional investor in the global energy and infrastructure sectors, today announced the completion of its acquisition of a 20% interest in PETRONAS’ key entities in Canada. The transaction includes a 20% interest in the North Montney Upstream Joint Venture (“NMJV”), which holds PETRONAS’ upstream investment in Canada, and a 20% interest in the North Montney LNG Limited Partnership (“NMLLP”), which holds PETRONAS’ 25% participating interest in the LNG Canada Project. This strategic investment positions MidOcean across the LNG value chain, securing upstream resources and downstream liquefaction through the LNG Canada Project, with around 0.7 MTPA of associated LNG and potential to grow further. RBC Capital Markets acted as financial advisor to MidOcean, and Latham & Watkins acted as legal advisor. About EIG EIG is a leading institutional investor in the global energy and infrastru

Nexo Announces Landmark Crypto Partnership with Tennis Australia for Australian Open and Summer of Tennis17.12.2025 10:00:00 EET | Press release

Nexo, the premier digital assets platform, has entered a landmark multi-year global partnership with Tennis Australia, becoming the Official Crypto Partner of the Australian Open and the Summer of Tennis, including the United Cup, Adelaide International, Brisbane International, and Hobart International. This agreement marks the first time a digital asset company has partnered with a Grand Slam tournament, affirming Nexo’s prestige, long-term vision, and leadership at the intersection of elite sport and digital assets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216497915/en/ Antoni Trenchev, Co-founder, Nexo, noted: “The Australian Open stands at the intersection of excellence and ambition – precisely where Nexo positions itself. Our partnership reflects a shared commitment to disciplined performance and long-term thinking. We are honored to join Tennis Australia in elevating the sport while showcasing the value of int

Outpost24 Secures New Investment to Scale its Exposure Management and Identity Security Solutions17.12.2025 09:00:00 EET | Press release

Outpost24, a leader in exposure management and identity security, today announced a new investment from Vitruvian Partners to fuel its next phase of global growth. This significant new funding will accelerate innovation across the company's platform, with a focus on integrating AI capabilities to optimize how security teams identify and neutralize critical vulnerabilities. The only European vendor recognized as an overall leader in the 2025 KuppingerCole Leadership Compass Report for Attack Surface Management, Outpost24 delivers a distinct approach to cyber defence that empowers security teams to gain a complete understanding of their digital and human risk landscape. Last week, Outpost24 announced the acquisition of Infinipoint, a specialist in device identity, posture validation, and secure workforce access. The acquisition marks the company's entry into the Zero Trust Workforce Access market and lays the foundation for its identity security division, Specops, to offer a unified appr

VeritasChain Unveils VAP Architecture, New Auditability Research, and Confirms Submissions to 58 Regulators Globally17.12.2025 09:00:00 EET | Press release

VeritasChain today unveiled its Verifiable AI Provenance Framework (VAP) architecture, published new research on verifiable audit trails, and confirmed informational submissions to 58 regulatory authorities across 43 jurisdictions. These milestones advance VeritasChain’s mission to establish a global framework for verifiable auditability in AI and algorithmic trading. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216433807/en/ Map indicates jurisdictions where regulatory outreach or informational submissions have been made as of Dec 2025. Verifiable AI Provenance Framework (VAP) VAP is a layered assurance architecture designed for independent verification of AI decision-making. It is not a single product, but a framework defining how cryptographic evidence and third-party verification interoperate across diverse systems. The architecture records decision-to-execution events as immutable audit trails, facilitating regulat

New Published Data Confirms Nemluvio ® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 08:00:00 EET | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements observed as early as 48 hours after treatment in some patients with atopic dermatitis and prurigo nodularis.1 The findings from post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs were published in the Journal of the European Academy of Dermatology and Venereology. Nemolizumab is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signalling of IL-31.2,5,6 IL-31 is a neuroimmune cytokine that drives itch and other symptoms in both atopic dermatitis and prurigo nodularis.3,4 These new findings reinforce the critical role of IL-31 pathway inhibition in achieving rapid itch response. Atopic dermatitis and prurigo nodularis are debilitating skin conditions that significantly affect quality of life, with symptoms such as per

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye